What is The Warning Statement On Infinis GLP-1
However, its important to note that at this stage, GLP-1 RAs should not be thought of as a cure for arthrofibrosis (or any form of fibrosis)
Yet many experts argue that lesion characteristics, in addition to size, should be considered in the classification criteria and ultimately risk stratification
Our courses are designed to provide you with the knowledge and skills you need to confidently offer B12 injections to your patients or clients
Trial Structure Duration: 48 weeks of treatment Participants: 338 adults randomized 2:1:1:1:1:2:2 to placebo or retatrutide groups Doses tested: 1mg, 4mg, 8mg, 12mg (all with slow titration from 2mg starting dose) Lifestyle intervention: All participants received counseling on diet (500 kcal/day deficit) and exercise (150 min/week) Primary endpoint: Percent weight change at 24 weeks Key secondary endpoints: Weight change at 48 weeks, proportion achieving 5%, 10%, 15% loss The trial used a slow titration protocol to minimize side effects: all groups except the 1mg dose started at 2mg weekly and escalated every 4 weeks